» Articles » PMID: 37339766

Sociodemographics, Clinical Factors, and Biological Factors Associated with Loiasis in Endemic Onchocerciasis Areas in Southern Gabon

Abstract

To implement the appropriate strategies for scale-up interventions to eliminate onchocerciasis without severe adverse events, clinical and biological factors associated with loiasis were analyzed in onchocerciasis-endemic areas. Blood was collected from volunteers after examination by a physician. Detection of microfilariae and measurement of Ov16 IgG4 were performed using direct microscopic examination of blood and onchocerciasis rapid test detection, respectively. Areas with sporadic, hypoendemic, and hyperendemic onchocerciasis endemicity were found. Participants with microfilaremia were considered microfilaremic, and those without microfilaremia were seen as amicrofilaremic. Of the 471 study participants, 40.5% (n = 191) had microfilariae. Among them, Mansonella spp. was the most common (78.2%, n = 147), followed by Loa loa (41.4%, n = 79). The association between the two species represented 18.3% (n = 35). The specific immunoglobulins of Onchocerca volvulus were detected in 24.2% of participants (n = 87/359). Overall prevalence of L. loa was 16.8%. Hypermicrofilaremia was found in 3% (N = 14), and one participant had more than 30,000 microfilaremiae per milliliter. The frequency of L. loa did not vary according to the level of onchocerciasis transmission. Pruritus was the most common clinical sign (60.5%, n = 285) reported, mainly in microfilaremic participants (72.2%, n = 138/191). The prevalence of L. loa microfilaria in the study population was below the threshold at risk for the occurrence of serious side effects due to ivermectin. Clinical manifestations frequently observed could be exacerbated by microfilaremia in areas where onchocerciasis transmission is high.

Citing Articles

Prevalence and Sociodemographic Risk Factors of Soil-Transmitted Helminths in Rural Communities Living in Endemic Foci of Onchocerciasis in Southern Gabon.

Moutongo Mouandza R, Mourou Mbina J, Moutombi Ditombi B, Mihindou J, Moussavou Mabicka D, Mayandza C Pathogens. 2024; 13(11).

PMID: 39599520 PMC: 11597376. DOI: 10.3390/pathogens13110967.

References
1.
Buell K, Whittaker C, Chesnais C, Jewell P, Pion S, Walker M . Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations. Open Forum Infect Dis. 2019; 6(11):ofz417. PMC: 6824532. DOI: 10.1093/ofid/ofz417. View

2.
Donohue R, Cross Z, Michael E . The extent, nature, and pathogenic consequences of helminth polyparasitism in humans: A meta-analysis. PLoS Negl Trop Dis. 2019; 13(6):e0007455. PMC: 6599140. DOI: 10.1371/journal.pntd.0007455. View

3.
Klion A, Massougbodji A, Sadeler B, Ottesen E, Nutman T . Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis. 1991; 163(6):1318-25. DOI: 10.1093/infdis/163.6.1318. View

4.
Veletzky L, Hergeth J, Stelzl D, Mischlinger J, Zoleko Manego R, Mombo-Ngoma G . Burden of disease in Gabon caused by loiasis: a cross-sectional survey. Lancet Infect Dis. 2020; 20(11):1339-1346. DOI: 10.1016/S1473-3099(20)30256-5. View

5.
Mbondoukwe N, Kendjo E, Mawili-Mboumba D, Koumba Lengongo J, Mbouoronde C, Nkoghe D . Prevalence of and risk factors for malaria, filariasis, and intestinal parasites as single infections or co-infections in different settlements of Gabon, Central Africa. Infect Dis Poverty. 2018; 7(1):6. PMC: 5789590. DOI: 10.1186/s40249-017-0381-4. View